Key Market Indicators
Estonian Blood and Blood Forming Organs Medicine Sales are set to rise to $59 million by 2026. Last year, sales reached $48 million and have been growing at a rate of 3 percent annually since 2004. In 2021, Estonia ranked 26th globally, with New Zealand coming in ahead of the Eastern European country at $48 million. Germany, Italy, and South Korea were the top three in the ranking, respectively.
